Le Lézard
Classified in: Health
Subjects: PSF, CFG

The Government of Canada introduces the Connected Care for Canadians Act


Improving patients' safety and access to their health information 

OTTAWA, ON, June 6, 2024 /CNW/ - Today, the Honourable Mark Holland, Minister of Health, introduced Bill C-72 the Connected Care for Canadians Act. This Act is about enabling Canadians to securely access their own health data, which will empower patient's decision-making and improve the care they receive from health providers in Canada. This Act outlines Canada's plan to enable a modern, connected care system, in which health information can be securely accessed by patients and shared between providers, when needed.

Enabling timely and secure access to personal health information is critical to saving lives and improving health care for Canadians. Every Canadian ? and their health care providers ? should be able to access their health information simply, securely, and digitally. However, less than 40% of Canadians currently report accessing some of their health information and only 35% of primary care physicians in Canada can share patient information outside their practice.   

Delayed access to personal health information causes harm to patients ? it can result in unnecessary or duplicative tests, longer wait times and hospital stays, and medication errors. When health providers and patients have access to health information, there are decreased re-admission rates, increased accuracy of diagnosis, increased quality of care, and fewer deaths. Connectivity will ease the burden on patients, families, and caregivers who must often recall and repeat their medical history. It also reduces stress on health care providers who are having to make decisions without access to all of the patient's information.

Canadians should feel safe knowing that their medical records are secure and protected, for their own use, and for the use of their health care providers. The legislation would require all IT companies providing digital health services in Canada to adopt common standards and allow for protected and secure information exchange across various systems.

Federal, provincial, and territorial governments are working together through the implementation of a Pan-Canadian Interoperability Roadmap that sets the path forward to connected care through common interoperability and data standards. The legislation aims to accelerate adoption of these standards and enable secure information sharing across platforms, but would only apply in provinces and territories that do not have similar legislation in place.   

The Government of Canada remains committed to collaborating with its provincial and territorial partners in the development of the regulation to ensure the protection and secure sharing of Canadians' own health data and to improve patient outcomes, while ensuring existing strict privacy legislation is respected. 

Quotes

"Data saves lives and it's time for us to move past the archaic and siloed approach to managing and sharing patient information. This legislation is about enabling Canadians to access their own health data and to use that information to make better decisions about their health care, no matter where in Canada they are receiving it. It will also allow health care professionals to deliver higher quality and coordinated care and make more informed patient decisions. Ultimately, this legislation will lead to improved health outcomes and will also help lay the foundation for a modernized, connected health system for all Canadians."

The Honourable Mark Holland
Minister of Health of Canada

Quick Facts
Associated Links

SOURCE Health Canada (HC)


These press releases may also interest you

at 05:00
Updated Phase 1 dose-escalation data from ARROS-1 and ALKOVE-1 clinical trials continue to support potential best-in-class profiles for zidesamtinib and NVL-655 Rapid enrollment in Phase 2 portions of the ARROS-1 and ALKOVE-1 clinical trials;...

at 04:20
Pfizer Inc. today announced longer-term follow-up results from the Phase 2 single-arm PHAROS clinical trial evaluating the efficacy and safety of BRAFTOVI® (encorafenib) in combination with MEKTOVI® (binimetinib) for patients with BRAF V600E-mutant...

at 04:06
Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology, announced the latest clinical data on...

at 03:20
Merck , known as MSD outside of the United States and Canada, today announced overall survival (OS) results from the final analysis of the Phase 3 KEYNOTE-811 trial evaluating KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with...

at 03:10
Nuvation Bio Inc. , a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced positive pooled data from the pivotal Phase 2 TRUST-I and TRUST-II studies evaluating taletrectinib, an...

at 03:10
Johnson & Johnson today announced updated results from the Phase 3 MARIPOSA-2 study which showed RYBREVANT® (amivantamab-vmjw) combined with chemotherapy led to consistent benefit across post-progression outcomes in adult patients with previously...



News published on and distributed by: